Lam Research Corporation
Lam is executing very well into an AI and memory upswing, but 54.44x earnings and 17.03x sales already discount a lot more than the current cycle likely merits.
Lam is not the problem. The stock price is. At $315.21, investors are paying 54.44x earnings and 17.03x sales for a wafer fab equipment company that is executing well but still operating in a cyclical industry with uneven regional demand and a history of sharp valuation resets. That premium might be easier to defend if cash generation were surging alongside earnings, but FY2026 FCF was only $0.8B, while inventory climbed to $4.3B and deferred revenue reached $2.43B.
The operating story is undeniably strong. FY2026 revenue rose 13.8% to $23.2B, EPS rose 21.2% to $5.79, and the latest quarter was a record with $6.72B of revenue and 38.6% EBITDA margin. Management then guided the September quarter to $8.1B of revenue and $2.15 of EPS, helped by NAND, advanced packaging, and broader AI-related memory spending. The company has now posted 8 straight EPS beats, so skepticism about execution is hard to support with facts.
The issue is what is already embedded in the stock. Even after a 28.1% drop from the $438.50 high, shares remain 16.3% above the 200-day average and still command a large premium to peers, whose average P/E is 33.1. That leaves little room for disappointment if the current margin profile eases, if China remains soft, or if elevated WFE expectations for 2027 prove more cyclical than structural. Rising long rates, with the 10-year Treasury at 5.18%, also make long-duration premium multiples harder to justify.
The case depends on three things: first, whether September-quarter strength becomes a stable FY27 run-rate; second, whether AI-led packaging and memory demand can offset weaker China mature-node spend; third, whether investors should keep assigning Lam a large premium despite a cyclical end-market. The first two look favorable. The third does not. That is why the call is SELL, but only with low conviction: this is a valuation fade against a very good business, not a broken-company short.
September quarter strength proves durable, FY27 earnings power resets sharply higher, and investors reward Lam's AI, NAND, and packaging exposure with a continued premium.
Lam delivers strong FY27 growth, but the market rerates the stock lower from 54.44x toward a more normal premium as cycle enthusiasm cools.
AI memory and packaging demand stays healthy but margins normalize, China remains weak, and the multiple compresses closer to equipment peers.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 15 buy / 1 hold / 0 sell) — resolve explicitly.
We suffer more often in imagination than in reality.
Forward earnings power is clearly improving, with a near-term setup that points far above FY2026's $5.79 EPS if Lam can hold close to the September guide of $2.15 EPS and 39.5% operating margin. Even so, the stock at $315.21 still asks investors to pay a premium multiple versus peers before that higher earnings base is fully proven. The moat remains real over the next 3 to 5 years, especially in etch, deposition, and process intensity tied to AI memory and advanced packaging, but regulation and a weaker China mix cap how far the market should stretch the multiple. AI is helping Lam, not disrupting it, but the debate now is less about demand and more about how much of that demand is already in the price.
- FY2026 revenue grew 13.8% to $23.2B and EPS grew 21.2% to $5.79, confirming real cyclical strength.
- Management guided the September quarter to $8.1B ± $0.4B revenue, 39.5% ± 1.0 pt operating margin, and $2.15 ± $0.15 EPS, well above recent run-rate.
- The stock trades at 54.44x P/E versus 33.1x peer average and the quant engine's blended target is $229.1, or -27.3% from $315.21.
- Execution has been clean: Lam has beaten EPS estimates in 8 straight quarters, with beats ranging from +3.3% to +9.9%, including +7.7% on 2026-07-29.
- Q4 FY2026 was strong on both demand and margins: EBITDA reached $2.59B on $6.72B revenue, a 38.6% margin, up 150 bps q/q and 230 bps y/y.
- AI-linked demand is showing up in real numbers, not narrative: management raised CY2026 WFE to the low $150B range from $140B, said advanced packaging should grow more than 70% y/y, and NAND revenue more than doubled sequentially.
- The balance sheet is solid for a cyclical equipment company, with Debt/EBITDA 0.47, Debt/Equity 0.33, and a 2.63 current ratio.
- Valuation is the core problem: 54.44x earnings, 17.03x sales, and 31.72x book are rich for a wafer fab equipment name, especially against a peer P/E of 33.1.
- Profitability at the full-year level is not moving in a straight line: FY2026 operating margin was 29.7%, down from 32.0% in the prior year, even as revenue grew.
- Cash conversion looks soft relative to the income statement: FY2026 FCF was only $0.8B against $23.2B revenue, while inventory rose to $4.3B and deferred revenue to $2.43B.
- China has turned from tailwind to drag at the margin: management said China domestic customer demand declined sequentially and mature-node China spending was lower.
| Metric | Value | Context |
|---|---|---|
| Current price | $315.21 | Reference point for the rating and scenario analysis |
| Quant price target | $229.1 | -27.3% vs current, Low confidence, basis: earnings_growth_blend |
| FY2026 revenue | $23.2B | +13.8% YoY |
| FY2026 EPS | $5.79 | +21.2% YoY |
| FY2026 operating margin | 29.7% | Down from 32.0% in the prior fiscal year |
| FY2026 net margin | 26.5% | Still very strong absolute profitability |
| Valuation | P/E 54.44 | P/S 17.03 | P/B 31.72 | Rich vs peer averages of 33.1x P/E and 10.9x P/S |
| Balance sheet | Debt/Equity 0.33 | Debt/EBITDA 0.47 | Current ratio 2.63 | Low leverage and healthy liquidity |
| Free cash flow | $0.8B | Modest relative to revenue, with capex at $0.6B |
| Q1 FY27 guidance | Revenue $8.1B ± $0.4B | EPS $2.15 ± $0.15 | Also guided gross margin 52.0% ± 1.0 pt and operating margin 39.5% ± 1.0 pt |
| WFE outlook | Low $150B range | Raised from prior $140B with upside bias |
| Price action | -28.1% vs 52-week high | +16.3% vs 200-day average | Off the peak, but not washed out |
The biggest risk to a SELL is that FY27 earnings power ramps much faster than expected if the $8.1B September guide proves sustainable and CY2027 WFE demand stays unusually strong.
The next catalyst is October 21, 2026 earnings, where investors need to see whether the $8.1B September revenue guide and 39.5% operating margin translate into a durable FY27 run-rate.
Ownership is crowded and institutional, with the top three holders at 78.5%, insider ownership only 0.3%, and short interest low at 2.09% or 26.1M shares. That is not the setup for a powerful squeeze, especially with short interest down 6% and only 2.4 days to cover. Options positioning is mildly supportive near term because GEX is positive and the zero-gamma level is $295.91, below spot, but that matters more for trading than for the 6 to 12 month fundamental case.
Detailed segment split was not provided, but management highlighted record CSBG upgrade revenue and sequentially more than doubling NAND revenue as key Q4 drivers.
A fast-growing subsegment, expected to grow more than 70% y/y in CY2026, helped by panel-level packaging shipments including the first 310x310-mm panel tool.
China mattered heavily two years ago, but current commentary turned softer, with domestic customer demand down sequentially and mature-node spending lower.
Lam posted record Q4 results and guided to $8.1B September revenue as AI-driven memory and packaging demand accelerates.
Management has earned credibility. In the 2025 Q1 call, Lam guided the December quarter to $4.3B ± $300M revenue, 47% ± 1 pt gross margin, 30% ± 1 pt operating margin, and $0.87 ± $0.10 EPS, while arguing 2025 would be a growth year and that Lam could outgrow WFE. Since then, the company has delivered 8 straight EPS beats, FY2026 revenue of $23.2B with 13.8% growth, FY2026 EPS of $5.79 with 21.2% growth, and now guides the September FY27 quarter to $8.1B revenue, 52.0% gross margin, 39.5% operating margin, and $2.15 EPS. The direction has not changed materially, it has improved: advanced packaging strengthened further, NAND recovered, and margins expanded in the latest quarter, although China normalized lower as management had foreshadowed.
Our $8.1 billion September quarter revenue guide represents more than 20% growth quarter-on-quarter.
We're expecting revenue of $8.1 billion, plus or minus $400 million. Gross margin of 52%, plus or minus 1 percentage point; operating margins of 39.5%, plus or minus 1 percentage point.
As we enter the second half of the year, we expect calendar 2026 wafer fab equipment spending or WFE to be in the low $150 billion range up from our prior outlook of $140 billion with upside bias.
Our revenue was above the midpoint of guidance. With gross margin, operating margin and earnings per share all exceeded the high end of our guided range.
It looks like it's going to set up to be a pretty darn good year, Jim.
Lam's moat sits in process know-how, tool performance, and the cost of changing qualified equipment in etch and deposition steps that directly affect yield. That advantage strengthens when process intensity rises, which is happening in 3D NAND, advanced memory, and advanced packaging for AI systems. The moat looks durable over the next 3 to 5 years because customers are adding more complex steps, not fewer, though it is not so unique that the stock deserves any price.
Capital allocation looks mostly disciplined, but not especially aggressive in FY2026. Lam generated $0.8B of FCF, spent $0.6B on capex, returned $0.2B via buybacks and $0.3B via dividends, while also carrying higher inventory to support demand. That is sensible for a cycle upswing, but the modest FCF result means the equity story currently relies more on earnings momentum than on cash return firepower.
Rated SELL, Low conviction. Lam is executing like a top-tier equipment company, and the AI, memory, and advanced packaging tailwinds are real, but the stock still prices in too much perfection at 54.44x earnings. The base case remains closer to the engine's $229.1 target than to a full recovery toward the old high. A move to neutral or bullish would require one of two things: either a materially lower entry price, or proof over multiple quarters that the September-quarter earnings power is sustainable enough to bring the forward P/E down sharply. Until then, this looks like a good company with a bad setup.
≣ Full research note tap to expand
Executive Summary
SELL, Low conviction. LRCX rates a SELL, Low conviction. The business is in strong shape, management is beating numbers, and the September guide to $8.1B of revenue is excellent, but the stock still screens expensive against both peers and the engine's $229.1 target, even after falling 28.1% from the high. The setup is not broken operationally, it is stretched on valuation.
Investment Thesis
Lam is not the problem. The stock price is. At $315.21, investors are paying 54.44x earnings and 17.03x sales for a wafer fab equipment company that is executing well but still operating in a cyclical industry with uneven regional demand and a history of sharp valuation resets. That premium might be easier to defend if cash generation were surging alongside earnings, but FY2026 FCF was only $0.8B, while inventory climbed to $4.3B and deferred revenue reached $2.43B.
The operating story is undeniably strong. FY2026 revenue rose 13.8% to $23.2B, EPS rose 21.2% to $5.79, and the latest quarter was a record with $6.72B of revenue and 38.6% EBITDA margin. Management then guided the September quarter to $8.1B of revenue and $2.15 of EPS, helped by NAND, advanced packaging, and broader AI-related memory spending. The company has now posted 8 straight EPS beats, so skepticism about execution is hard to support with facts.
The issue is what is already embedded in the stock. Even after a 28.1% drop from the $438.50 high, shares remain 16.3% above the 200-day average and still command a large premium to peers, whose average P/E is 33.1. That leaves little room for disappointment if the current margin profile eases, if China remains soft, or if elevated WFE expectations for 2027 prove more cyclical than structural. Rising long rates, with the 10-year Treasury at 5.18%, also make long-duration premium multiples harder to justify.
The case depends on three things: first, whether September-quarter strength becomes a stable FY27 run-rate; second, whether AI-led packaging and memory demand can offset weaker China mature-node spend; third, whether investors should keep assigning Lam a large premium despite a cyclical end-market. The first two look favorable. The third does not. That is why the call is SELL, but only with low conviction: this is a valuation fade against a very good business, not a broken-company short.
Key Metrics
| Metric | Value | Context | ||
|---|---|---|---|---|
| Current price | $315.21 | Reference point for the rating and scenario analysis | ||
| Quant price target | $229.1 | -27.3% vs current, Low confidence, basis: earnings_growth_blend | ||
| FY2026 revenue | $23.2B | +13.8% YoY | ||
| FY2026 EPS | $5.79 | +21.2% YoY | ||
| FY2026 operating margin | 29.7% | Down from 32.0% in the prior fiscal year | ||
| FY2026 net margin | 26.5% | Still very strong absolute profitability | ||
| Valuation | P/E 54.44 | P/S 17.03 | P/B 31.72 | Rich vs peer averages of 33.1x P/E and 10.9x P/S |
| Balance sheet | Debt/Equity 0.33 | Debt/EBITDA 0.47 | Current ratio 2.63 | Low leverage and healthy liquidity |
| Free cash flow | $0.8B | Modest relative to revenue, with capex at $0.6B | ||
| Q1 FY27 guidance | Revenue $8.1B ± $0.4B | EPS $2.15 ± $0.15 | Also guided gross margin 52.0% ± 1.0 pt and operating margin 39.5% ± 1.0 pt | |
| WFE outlook | Low $150B range | Raised from prior $140B with upside bias | ||
| Price action | -28.1% vs 52-week high | +16.3% vs 200-day average | Off the peak, but not washed out |
Financial Strength
Lam's financial profile is fundamentally strong. Leverage is low, liquidity is healthy, and profitability remains high enough to absorb investment in inventory, field capacity, and R&D. The one blemish is cash conversion: $0.8B of FCF is light relative to the earnings and revenue base, suggesting working capital is doing some of the heavy lifting in this phase of the cycle. That does not threaten the balance sheet, but it does matter when the equity is priced at a premium multiple.
Competitive Position
Lam's moat sits in process know-how, tool performance, and the cost of changing qualified equipment in etch and deposition steps that directly affect yield. That advantage strengthens when process intensity rises, which is happening in 3D NAND, advanced memory, and advanced packaging for AI systems. The moat looks durable over the next 3 to 5 years because customers are adding more complex steps, not fewer, though it is not so unique that the stock deserves any price.
Management & Guidance
Current guidance is aggressive and credible. Management said, "Our $8.1 billion September quarter revenue guide represents more than 20% growth quarter-on-quarter," and the company has earned the benefit of the doubt after exceeding the high end of revenue, gross margin, operating margin, and EPS guidance in the June quarter. The FY27 September outlook of 52.0% gross margin and 39.5% operating margin is a major step up from FY2026's 29.7% full-year operating margin, so the key question is not whether Lam can beat a quarter, but how much of that elevated earnings power is durable beyond the initial AI-memory surge and higher tax rate in the mid-teens.
Segment Analysis
- Systems and installed-base services mix (N/A): Detailed segment split was not provided, but management highlighted record CSBG upgrade revenue and sequentially more than doubling NAND revenue as key Q4 drivers.
- Advanced packaging (N/A): A fast-growing subsegment, expected to grow more than 70% y/y in CY2026, helped by panel-level packaging shipments including the first 310x310-mm panel tool.
- China (Historical mix ~30% in Dec FY2025 guide): China mattered heavily two years ago, but current commentary turned softer, with domestic customer demand down sequentially and mature-node spending lower.
Capital Allocation
Capital allocation looks mostly disciplined, but not especially aggressive in FY2026. Lam generated $0.8B of FCF, spent $0.6B on capex, returned $0.2B via buybacks and $0.3B via dividends, while also carrying higher inventory to support demand. That is sensible for a cycle upswing, but the modest FCF result means the equity story currently relies more on earnings momentum than on cash return firepower.
Management Execution & Track Record
Management has earned credibility. In the 2025 Q1 call, Lam guided the December quarter to $4.3B ± $300M revenue, 47% ± 1 pt gross margin, 30% ± 1 pt operating margin, and $0.87 ± $0.10 EPS, while arguing 2025 would be a growth year and that Lam could outgrow WFE. Since then, the company has delivered 8 straight EPS beats, FY2026 revenue of $23.2B with 13.8% growth, FY2026 EPS of $5.79 with 21.2% growth, and now guides the September FY27 quarter to $8.1B revenue, 52.0% gross margin, 39.5% operating margin, and $2.15 EPS. The direction has not changed materially, it has improved: advanced packaging strengthened further, NAND recovered, and margins expanded in the latest quarter, although China normalized lower as management had foreshadowed.
Positioning & Flows
Ownership is crowded and institutional, with the top three holders at 78.5%, insider ownership only 0.3%, and short interest low at 2.09% or 26.1M shares. That is not the setup for a powerful squeeze, especially with short interest down 6% and only 2.4 days to cover. Options positioning is mildly supportive near term because GEX is positive and the zero-gamma level is $295.91, below spot, but that matters more for trading than for the 6 to 12 month fundamental case.
Bull Case
- Execution has been clean: Lam has beaten EPS estimates in 8 straight quarters, with beats ranging from +3.3% to +9.9%, including +7.7% on 2026-07-29.
- Q4 FY2026 was strong on both demand and margins: EBITDA reached $2.59B on $6.72B revenue, a 38.6% margin, up 150 bps q/q and 230 bps y/y.
- AI-linked demand is showing up in real numbers, not narrative: management raised CY2026 WFE to the low $150B range from $140B, said advanced packaging should grow more than 70% y/y, and NAND revenue more than doubled sequentially.
- The balance sheet is solid for a cyclical equipment company, with Debt/EBITDA 0.47, Debt/Equity 0.33, and a 2.63 current ratio.
Bear Case
- Valuation is the core problem: 54.44x earnings, 17.03x sales, and 31.72x book are rich for a wafer fab equipment name, especially against a peer P/E of 33.1.
- Profitability at the full-year level is not moving in a straight line: FY2026 operating margin was 29.7%, down from 32.0% in the prior year, even as revenue grew.
- Cash conversion looks soft relative to the income statement: FY2026 FCF was only $0.8B against $23.2B revenue, while inventory rose to $4.3B and deferred revenue to $2.43B.
- China has turned from tailwind to drag at the margin: management said China domestic customer demand declined sequentially and mature-node China spending was lower.
Valuation & Price Target
Engine price target $229.1 (-27.3% vs current), Low confidence.
- P/E Multiple: $270.29 (28% weight)
- PEG (growth-adjusted): $119.85 (20% weight)
- P/S Multiple: $186.3 (20% weight)
- Quality-adjusted: $365.64 (20% weight)
- DCF: $58.21 (5% weight)
The rating stays aligned with the quant baseline at SELL, though with Low conviction because the business momentum is stronger than a simple valuation screen suggests. The engine's $229.1 target is supported by expensive headline valuation, 54.44x P/E against 33.1x peers, and by wide peer dispersion of 4.3x, which limits confidence in comparables. The reason this is not a high-conviction SELL is that management is executing extremely well, the September guide is far above FY2026 run-rate, leverage is low at 0.47x Debt/EBITDA, and AI-driven memory and packaging demand are real. Sell-side consensus sits at 15 buy / 1 hold / 0 sell, but that is low-signal context here and does not offset the basic issue that fundamentals are strong while the stock is still priced for even better outcomes.
Risk Assessment
Risk score 35/100 (Low). The biggest risk to a SELL is that FY27 earnings power ramps much faster than expected if the $8.1B September guide proves sustainable and CY2027 WFE demand stays unusually strong.
The Bottom Line
Rated SELL, Low conviction. Lam is executing like a top-tier equipment company, and the AI, memory, and advanced packaging tailwinds are real, but the stock still prices in too much perfection at 54.44x earnings. The base case remains closer to the engine's $229.1 target than to a full recovery toward the old high. A move to neutral or bullish would require one of two things: either a materially lower entry price, or proof over multiple quarters that the September-quarter earnings power is sustainable enough to bring the forward P/E down sharply. Until then, this looks like a good company with a bad setup.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr